Literature DB >> 25656998

Thymic stromal lymphopoietin and IL-33 modulate migration of hematopoietic progenitor cells in patients with allergic asthma.

Steven G Smith1, Akash Gugilla1, Manali Mukherjee1, Kayla Merim1, Anam Irshad1, Wei Tang2, Takashi Kinoshita2, Brittany Watson2, John-Paul Oliveria2, Mike Comeau3, Paul M O'Byrne2, Gail M Gauvreau2, Roma Sehmi4.   

Abstract

BACKGROUND: Thymic stromal lymphopoietin (TSLP) and IL-33 are considered important initiators of type 2 immunity. In asthmatic patients allergic inflammatory responses are associated with increased lung homing of bone marrow-derived CD34(+) hematopoietic progenitor cells (HPCs), which include eosinophil lineage-committed progenitor cells. In this study we investigated the role of TSLP and IL-33 in the recruitment of progenitor cells to the airways in asthmatic subjects.
OBJECTIVES: We sought (i) to examine the effect of allergen inhalation challenge on expression levels of receptors for TSLP (thymic stromal lymphopoietin receptor [TSLPR] and CD127) and IL-33 (ST2) and (ii) investigate the functional effects of these cytokines on HPCs.
METHODS: Consenting patients with mild atopic asthma (n = 19) with an FEV1 of 70% or greater and methacholine PC20 of 16 mg/mL or less were recruited. Blood- and sputum-extracted progenitors were phenotyped by flow cytometry before and 24 hours after allergen challenge. Functional responses, including cytokine production and migration to TSLP and IL-33, were assessed in vitro.
RESULTS: Significant increases in mature eosinophil, HPC, and eosinophil lineage-committed progenitor cell counts in sputum were observed 24 hours after allergen and were associated with a significant allergen-induced increase in HPCs expressing TSLPR, CD127, and ST2. Pre-exposure to TSLP and IL-33 primed the migration of HPCs to a potent progenitor cell chemoattractant, stromal cell-derived factor 1α (CXCL12). Incubation with TSLP and IL-33 stimulated significant production of IL-5 and IL-13, but not IL-4, by HPCs. This priming effect was inhibited by blocking antibodies to TSLPR and ST2, respectively, and IL-13 receptor α1 in both scenarios.
CONCLUSIONS: In allergic asthmatic responses increased lung homing of HPCs may be orchestrated by TSLP and IL-33 through an IL-13-dependent axis.
Copyright © 2015 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hematopoietic progenitor cells; asthma; thymic stromal lymphopoietin

Mesh:

Substances:

Year:  2015        PMID: 25656998     DOI: 10.1016/j.jaci.2014.12.1918

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  25 in total

Review 1.  Biological therapies for eosinophilic gastrointestinal diseases.

Authors:  Joshua B Wechsler; Ikuo Hirano
Journal:  J Allergy Clin Immunol       Date:  2018-05-31       Impact factor: 10.793

Review 2.  Shaping eosinophil identity in the tissue contexts of development, homeostasis, and disease.

Authors:  Hiam Abdala-Valencia; Mackenzie E Coden; Sergio E Chiarella; Elizabeth A Jacobsen; Bruce S Bochner; James J Lee; Sergejs Berdnikovs
Journal:  J Leukoc Biol       Date:  2018-04-14       Impact factor: 4.962

Review 3.  TSLP Inhibitors for Asthma: Current Status and Future Prospects.

Authors:  Maria Gabriella Matera; Paola Rogliani; Luigino Calzetta; Mario Cazzola
Journal:  Drugs       Date:  2020-04       Impact factor: 9.546

Review 4.  IL-33 in Chronic Respiratory Disease: From Preclinical to Clinical Studies.

Authors:  Chantal Donovan; Philip M Hansbro
Journal:  ACS Pharmacol Transl Sci       Date:  2019-12-20

Review 5.  Are We Meeting the Promise of Endotypes and Precision Medicine in Asthma?

Authors:  Anuradha Ray; Matthew Camiolo; Anne Fitzpatrick; Marc Gauthier; Sally E Wenzel
Journal:  Physiol Rev       Date:  2020-01-09       Impact factor: 37.312

Review 6.  New insights into basophil heterogeneity.

Authors:  Landon K Oetjen; Mario Noti; Brian S Kim
Journal:  Semin Immunopathol       Date:  2016-05-13       Impact factor: 9.623

7.  Eosinophil progenitor levels are increased in patients with active pediatric eosinophilic esophagitis.

Authors:  David W Morris; Emily M Stucke; Lisa J Martin; J Pablo Abonia; Vincent A Mukkada; Philip E Putnam; Marc E Rothenberg; Patricia C Fulkerson
Journal:  J Allergy Clin Immunol       Date:  2016-05-16       Impact factor: 10.793

8.  Eotaxin-Rich Proangiogenic Hematopoietic Progenitor Cells and CCR3+ Endothelium in the Atopic Asthmatic Response.

Authors:  Kewal Asosingh; Amit Vasanji; Aaron Tipton; Kimberly Queisser; Nicholas Wanner; Allison Janocha; Deepa Grandon; Bela Anand-Apte; Marc E Rothenberg; Raed Dweik; Serpil C Erzurum
Journal:  J Immunol       Date:  2016-01-25       Impact factor: 5.422

Review 9.  Tezepelumab: A Potential New Biological Therapy for Severe Refractory Asthma.

Authors:  Corrado Pelaia; Giulia Pelaia; Claudia Crimi; Angelantonio Maglio; Luca Gallelli; Rosa Terracciano; Alessandro Vatrella
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

10.  IL-33 Precedes IL-5 in Regulating Eosinophil Commitment and Is Required for Eosinophil Homeostasis.

Authors:  Laura K Johnston; Chia-Lin Hsu; Rebecca A Krier-Burris; Krishan D Chhiba; Karen B Chien; Andrew McKenzie; Sergejs Berdnikovs; Paul J Bryce
Journal:  J Immunol       Date:  2016-09-28       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.